Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria S. Sayapina"'
Autor:
Maria S. Sayapina, Nikita A. Savelov, Apollon I. Karseladze, Anatoly A. Bulanov, Alexey A. Tryakin, Dmitry A. Nosov, Avgust M. Garin, Sergey A. Tjulandin
Publikováno v:
Rare Tumors, Vol 8, Iss 2 (2016)
Nuclear protein of the testis (NUT) midline carcinomas are rare aggressive carcinomas characterized by chromosomal rearrangements that involve the gene encoding the NUT. This article reviews the clinicopathologic features and the differential diagnos
Externí odkaz:
https://doaj.org/article/5b9f88d168e14252a3dbe98f46e86bab
Autor:
Pasquale F. Innominato, Evgeny Y. Parnes, Maria S. Sayapina, Francis Lévi, Alexey Tryakin, René Adam, Jean-François Morère, Mohamed Bouchahda
Publikováno v:
Surgical Science. :358-366
Background: The regional chronomodulated hepatic arterial infusion chemotherapy (HAIC) is an effective regimen for the treatment of patients with unresectable liver metastases from colorectal cancer, especially for the conversion into resectability.
Autor:
Bykovskaia Sn, Maria S. Sayapina
Publikováno v:
Journal of Oncology, Vol 2018 (2018)
Aims. To examine changes in subpopulation of CD4+CD25+Foxp3+CD127low T lymphocytes (Treg) and their association with the efficiency of the IFN-α therapy. Materials and Methods. Pts with mRCC who had undergone nephrectomy were treated with IFN-α at
Autor:
Nikita A. Savelov, Anatoly Bulanov, Dmitry A. Nosov, Avgust Garin, Maria S. Sayapina, Apollon Karseladze, S. A. Tjulandin, Alexey Tryakin
Publikováno v:
Rare Tumors, Vol 8, Iss 2 (2016)
Rare Tumors
Rare Tumors
Nuclear protein of the testis (NUT) midline carcinomas are rare aggressive carcinomas characterized by chromosomal rearrangements that involve the gene encoding the NUT. This article reviews the clinicopathologic features and the differential diagnos
Publikováno v:
Journal of Oncology
Aims To examine changes in subpopulation of CD4+CD25+Foxp3+CD127low T lymphocytes (Treg) and their association with the efficiency of the IFN-α therapy. Materials and Methods Pts with mRCC who had undergone nephrectomy were treated with IFN-α at a